Antithrombin III (human)

Antithrombin III (human)
Trade Name Atnativ
Orphan Indication For the treatment of patients with hereditary antithrombin III deficiency in connection with surgical or obstetrical procedures or when they suffer from thromboembolism
USA Market Approval USA
USA Designation Date 1985-02-08 00:00:00
Sponsor Pharmacia & Upjohn AB;Lindhagensgatan 133, Stockholm;